![Bottles containing Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. These two preparations, of Stock Photo - Alamy Bottles containing Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. These two preparations, of Stock Photo - Alamy](https://c8.alamy.com/comp/2ADE73R/bottles-containing-moroctocog-alfa-trade-name-refacto-blood-clotting-factor-viii-concentrate-used-to-treat-haemophilia-these-two-preparations-of-2ADE73R.jpg)
Bottles containing Moroctocog alfa (trade name ReFacto) blood clotting factor VIII concentrate, used to treat haemophilia. These two preparations, of Stock Photo - Alamy
![National Hemophilia Foundation Revises Treatment Guidelines for Factor 1 Deficiency to Include Octapharma's fibryga® | Business Wire National Hemophilia Foundation Revises Treatment Guidelines for Factor 1 Deficiency to Include Octapharma's fibryga® | Business Wire](https://mms.businesswire.com/media/20201007005220/en/828106/5/US_fibryga_1g_Box_Device_CD1_72dpi.jpg)
National Hemophilia Foundation Revises Treatment Guidelines for Factor 1 Deficiency to Include Octapharma's fibryga® | Business Wire
![Coagulation Disorders - Hematologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed. Coagulation Disorders - Hematologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.](https://doctorlib.info/pharmacology/pharmacotherapy-pathophysiologic-approach/pharmacotherapy-pathophysiologic-approach.files/image1398.png)
Coagulation Disorders - Hematologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
![Plasma Derived Factor Concentrate > Factor Concentrates > Treatment > HoG Handbook > Hemophilia of Georgia Plasma Derived Factor Concentrate > Factor Concentrates > Treatment > HoG Handbook > Hemophilia of Georgia](https://www.hog.org/imgLib/201201091_RecombinantFactor.jpg)
Plasma Derived Factor Concentrate > Factor Concentrates > Treatment > HoG Handbook > Hemophilia of Georgia
![Blood Clotting Factor Ix Acrylic Print by Antonia Reeve/science Photo Library - Science Photo Gallery Blood Clotting Factor Ix Acrylic Print by Antonia Reeve/science Photo Library - Science Photo Gallery](https://render.fineartamerica.com/images/rendered/default/acrylic-print/10/6.5/hangingwire/break/images-medium-5/blood-clotting-factor-ix-antonia-reevescience-photo-library.jpg)
Blood Clotting Factor Ix Acrylic Print by Antonia Reeve/science Photo Library - Science Photo Gallery
![Blood Clotting Factor Concentrate Canvas Print / Canvas Art by Antonia Reeve/science Photo Library - Fine Art America Blood Clotting Factor Concentrate Canvas Print / Canvas Art by Antonia Reeve/science Photo Library - Fine Art America](https://render.fineartamerica.com/images/rendered/small/greeting-card/images-medium-5/blood-clotting-factor-concentrate-antonia-reevescience-photo-library.jpg?transparent=0&targetx=0&targety=-25&imagewidth=500&imageheight=750&modelwidth=500&modelheight=700&backgroundcolor=6FD9C6&orientation=1&producttype=greetingcard)
Blood Clotting Factor Concentrate Canvas Print / Canvas Art by Antonia Reeve/science Photo Library - Fine Art America
![Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ece86af5af20b7c268ad8e5a0dda435bafa54ff3/4-Table1-1.png)
Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar
![Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ece86af5af20b7c268ad8e5a0dda435bafa54ff3/8-Table3-1.png)
Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia | Semantic Scholar
![HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS | Jason and Jarvis Associates, LLC HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS | Jason and Jarvis Associates, LLC](https://www.jasonandjarvis.com/wp-content/uploads/1985/04/factor-concentrate.jpg)
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS | Jason and Jarvis Associates, LLC
![Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays - Peyvandi - 2020 - Journal of Thrombosis and Haemostasis - Wiley Online Library Laboratory testing in hemophilia: Impact of factor and non‐factor replacement therapy on coagulation assays - Peyvandi - 2020 - Journal of Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d249b6fe-34c3-4012-8aaa-62d0344139a9/jth14784-fig-0001-m.jpg)